These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
670 related articles for article (PubMed ID: 27662290)
1. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease. Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F; J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290 [TBL] [Abstract][Full Text] [Related]
2. Investigation on the Role of BDNF in the Benefits of Blueberry Extracts for the Improvement of Learning and Memory in Alzheimer's Disease Mouse Model. Tan L; Yang H; Pang W; Li H; Liu W; Sun S; Song N; Zhang W; Jiang Y J Alzheimers Dis; 2017; 56(2):629-640. PubMed ID: 28035919 [TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease. Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679 [TBL] [Abstract][Full Text] [Related]
4. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease. Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283 [TBL] [Abstract][Full Text] [Related]
5. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies. Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360 [TBL] [Abstract][Full Text] [Related]
6. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
7. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease. Wu X; Kosaraju J; Zhou W; Tam KY ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988 [TBL] [Abstract][Full Text] [Related]
9. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994 [TBL] [Abstract][Full Text] [Related]
10. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound. Baazaoui N; Iqbal K J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background. Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
14. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
15. Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease. Vepsäläinen S; Koivisto H; Pekkarinen E; Mäkinen P; Dobson G; McDougall GJ; Stewart D; Haapasalo A; Karjalainen RO; Tanila H; Hiltunen M J Nutr Biochem; 2013 Jan; 24(1):360-70. PubMed ID: 22995388 [TBL] [Abstract][Full Text] [Related]
16. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD). Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833 [TBL] [Abstract][Full Text] [Related]
17. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice. Kapadia M; Mian MF; Michalski B; Azam AB; Ma D; Salwierz P; Christopher A; Rosa E; Zovkic IB; Forsythe P; Fahnestock M; Sakic B J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702 [TBL] [Abstract][Full Text] [Related]
18. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease. Baazaoui N; Flory M; Iqbal K J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506 [TBL] [Abstract][Full Text] [Related]
19. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
20. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]